Physician profile

Brooke N Counce

Family · Nashville, TN

NPI 1922630417

$11,765.78

in general payments reported to CMS, 2019-2025

42 companies · $2,905 in 2025

The $2,905 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).

See the full distribution for Family

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,312.42
Education$105.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $1,746.97 2021-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Astrazeneca Pharmaceuticals LP $1,534.16 2021-2025 Fasenra, Airsupra, Breztri
Glaxosmithkline, LLC. $1,138.72 2021-2025 Nucala, Trelegy Ellipta, Arexvy
Regeneron Healthcare Solutions, INC. $888.52 2021-2025 Dupixent
Genzyme Corporation $883.50 2021-2025
Insmed, INC. $711.53 2022-2025 Arikayce, Brinsupri
Grifols USA, LLC $599.68 2021-2025 Prolastin-C Liquid
Actelion Pharmaceuticals US, INC. $556.49 2021-2025 Opsumit, Uptravi
Mylan Specialty L.P. $387.89 2021-2024 Yupelri
Inspire Medical Systems, INC. $371.49 2022-2025 Inspire
United Therapeutics Corporation $361.56 2022-2025 Tyvaso, Tyvaso
Jazz Pharmaceuticals INC. $332.34 2021-2025
Merck Sharp & Dohme LLC $267.36 2023-2025 Winrevair, Zerbaxa, Keytruda
Verona Pharma, INC. $234.50 2025 Ohtuvayre
Baxter Healthcare $187.83 2022-2025 Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Harmony Biosciences LLC $154.43 2024-2025
Amgen INC. $144.81 2022-2025 Tezspire
Vifor Pharma, INC. $134.46 2024-2025 Zemaira
Bayer Healthcare Pharmaceuticals INC. $125.27 2022-2025
Electromed, INC. $112.47 2023-2024 Smartvest
Sanofi-Aventis U.S. LLC $99.99 2023
Janssen Pharmaceuticals, INC $88.30 2023-2024 Xarelto
Viatris Specialty LLC $82.28 2025 Yupelri
Philips North America LLC $79.45 2021-2025 Vest Therapy Und
Axsome Therapeutics, INC. $67.49 2023 Sunosi
Avadel Cns Pharmaceuticals, LLC $59.58 2025 Lumryz
Takeda Pharmaceuticals U.S.A., INC. $58.33 2022
Pfizer INC. $46.65 2024-2025
Body Vision Medical INC. $39.07 2023 Lungvision
Mallinckrodt Hospital Products INC. $33.60 2022
Lilly USA, LLC $31.55 2025 Zepbound
Advanced Respiratory, INC $31.30 2021
Fisher & Paykel Healthcare INC $25.84 2022
Ambu INC. $25.73 2022
Vapotherm INC $19.29 2022
Ani Pharmaceuticals, INC. $16.87 2023 Purified Cortrophin Gel
Azurity Pharmaceuticals, INC. $16.30 2023 Horizant
Alexion Pharmaceuticals, INC. $15.09 2022
Sandoz INC. $14.27 2024 Treprostinil
Eisai INC. $13.96 2021
Genentech USA, INC. $13.48 2023 Xolair
Paratek Pharmaceuticals, INC. $13.38 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brooke N Counce

$11,765.78

in general payments reported 2019-2025

Years
2021-2025
Top company
Boehringer Ingelheim Pharmaceuticals, INC.
Context
The $2,905 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/11239208/brooke-n-counce

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.